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Neuronal calcium sensor-1 (NCS-1) or the originally
identified homologue frequenin belongs to a superfam-
ily of EF-hand calcium binding proteins. Although
NCS-1 is thought to enhance synaptic efficacy or exocy-
tosis mainly by activating ion channel function, the de-
tailed molecular basis for the enhancement is still a
matter of debate. Here, mechanisms underlying the
NCS-1-evoked enhancement of exocytosis were investi-
gated using PC12 cells overexpressing NCS-1. NCS-1 was
found to have a broad distribution in the cells being
partially distributed in the cytosol and associated to
vesicles and tubular-like structures. Biochemical and
immunohistochemical studies indicated that NCS-1 par-
tially colocalized with the light synaptic vesicle marker
synaptophysin. When stimulated with UTP or bradyki-
nin, agonists to phospholipase C-linked receptors,
NCS-1 enhanced the agonist-mediated elementary and
global Ca2 signaling and increased the levels of down-
stream signals of phosphatidylinositol 4-kinase. NCS-1
enhanced the UTP-evoked exocytosis but not the depo-
larization-evoked Ca2 responses or exocytosis, suggest-
ing that the enhancement by NCS-1 should involve phos-
pholipase C-linked receptor-mediated signals rather
than the Ca2 channels or exocytotic machinery per se.
Taken together, NCS-1 enhances phosphoinositide turn-
over, resulting in enhancement of Ca2 signaling and
exocytosis. This is a novel regulatory mechanism of exo-
cytosis that might involve the activation of phosphati-
dylinositol 4-kinase.
EF-hand-containing Ca2-binding proteins include those of
the neuronal calcium sensor family. This family of relatively
small proteins (30 kDa) is expressed in neuronal and neu-
roendocrine cell types and includes recoverin/S-modulin, visi-
nin, visinin-like protein, neurocalcin, hippocalcin, frequenin,
and neuronal Ca2 sensor-1 (NCS-1)1 (1). Recoverin has a well
defined role in signal transduction, regulating rhodopsin phos-
phorylation by inhibiting rhodopsin kinase (2). However, the
functions of the other members of this family are unclear.
Frequenin markedly enhances synaptic efficacy by increas-
ing neurotransmitter release in Drosophila (3) and Xenopus (4)
through unknown mechanisms. Furthermore, the expression of
NCS-1 (the mammalian homologue of frequenin) in other se-
cretory cell types such as chromaffin cells suggests a more
generalized role in exocytosis (5, 6). In a model of synaptic
transmission in PC12 cells, NCS-1 potentiated ATP-mediated
exocytosis of dense core granules but did not affect Ca2-in-
duced exocytosis in permeabilized PC12 cells, suggesting that
regulation by NCS-1 may be at the level of signal transduction
rather than through direct effects on the exocytotic machinery
(5, 6). Although the precise mechanisms for such enhancement
remain unknown, recent accumulating evidence suggests that
NCS-1 or frequenin could modulate ion channels such as non-
L-type (7, 8) and P/Q-type (9) voltage-gated Ca2 channels and
A-type K channel (10), which may explain such an increased
exocytosis.
In addition to ion channels, NCS-1 and/or frequenin binds to
multiple proteins such as G-protein receptor kinase 1 (11, 12) to
regulate exocytosis and to substitute for calmodulin (13). Re-
cently, the yeast frequenin, but not vertebrate NCS-1 (14), has
been demonstrated to bind to and activate phosphatidylinositol
4-OH kinase, a phosphatidylinositol 4-kinase (PtdIns4K) iso-
form (1). This class of enzyme is key to the supply of the
phospholipase C substrate phosphatidylinositol 4,5-bisphos-
phate (PtdIns(4,5)P2) and therefore has the potential to regu-
late phosphoinositide and Ca2 signaling mediated by G-pro-
tein-coupled receptors (GPCRs) and receptor tyrosine kinases.
The potentiation of this signaling pathway may explain the
enhancement of GPCR-mediated vesicle exocytosis by NCS-1.
In the current study, we sought to test this hypothesis by
examining the subcellular distribution of NCS-1 and its influ-
ence on GPCR-mediated phosphoinositide, elementary and/or
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global Ca2 signaling, and exocytosis in PC12 cells. The immu-
nolocalization of NCS-1 is consistent with a role for this protein
in exocytosis. Further, we demonstrate that NCS-1 enhances
UTP- and bradykinin-evoked exocytosis, and this is associated
with enhanced agonist-mediated phosphoinositide signaling
and potentiated elementary/global Ca2 signaling events.
These data suggest that the regulation of a PtdIns4K activity
by NCS-1 (1) occurs in mammalian cells and could be the
mechanism by which this protein enhances exocytotic
responses.
EXPERIMENTAL PROCEDURES
Cell Culture and Generation of NCS-1-overexpressing PC12 Cells—
PC12 cells were grown as described previously (15). To establish stable
NCS-1 clones, PC12 cells were transfected with the rat ncs-1 cDNA
(GenBankTM accession number L27421) in pClNeo (kindly provided by
Jan Eggermont) and selected for neomycin resistance following stand-
ard protocols. Stable clones were further characterized by Western
blotting and immunofluorescence as described below.
Subcellular Fractionation—NCS-1 cells were subjected to subcellu-
lar fractionation as previously described (16, 17) with minor modifica-
tions. Briefly, cells were homogenized in buffer containing 0.25 M su-
crose, 1 mM (CH3COO)2Mg, 2 mM EDTA, 10 mM HEPES, pH 7.4, with
NaOH and supplemented with protease inhibitors (10 mg/ml aprotinin,
2 mg/ml pepstatin A). To separate the membranes from cytosol, the
postnuclear supernatant (PNS) was centrifuged at 80,000  g for 20
min in a TLA 100.3 rotor using a Beckman Optima TL ultracentrifuge.
The pellets were resuspended in homogenization buffer, loaded on the
top of sucrose gradients (0.3–1.2 M sucrose), and then centrifuged at
110,000  g for 30 min (velocity gradient). Fractions of 1 ml were
collected from the top of the velocity gradients. 300 l of each fraction
from 4 to 8 were pooled and loaded on second sucrose gradients (1.1–2.0
M) and centrifuged at 110,000  g for 18 h (equilibrium gradients).
Equal aliquots (250 l) of both gradient fractions and equal amounts of
proteins of PNS prepared from wild type and NCS-1 cells were analyzed
by Western blotting as described (18). Briefly, after electrophoresis,
samples were electroblotted to nitrocellulose filters (Schleicher &
Schuell) and probed with antibodies. The blots were then washed and
incubated with the appropriate secondary antibodies conjugated to
peroxidase. The peroxidase was detected using chemiluminescent sub-
strate (Pierce). The levels of NCS-1 in the PNS were quantified by
measuring the intensity of the bands in the autoradiograms using the
analysis program Image 1.61 (National Technical Information Service,
Springfield, VA).
Immunocytochemistry—Double immunofluorescence and confocal
analysis on fixed cells were carried out as described (18). Briefly, the
fixed cells were permeabilized with Triton X-100 and then incubated
with the polyclonal anti-NCS-1 antibody and monoclonal antibodies
against either synaptophysin or chromogranin B. After washing, the
cells were incubated with the appropriate secondary antibodies conju-
gated to TRITC or fluorescein isothiocyanate, washed again, and
mounted on glass coverslips with Mowiol. Images were collected in the
MRC-1024 laser-scanning microscope (Bio-Rad) with 40 or 60 objec-
tive lenses. For comparison of double-stained patterns, images from the
fluorescein isothiocyanate or TRITC channels were acquired independ-
ently from the same area of sample and then superimposed. Images
were processed using Photoshop 4 (Adobe Systems, Mountain View,
CA). Immunolabeling of frozen sections prepared from fixed and su-
crose-embedded NCS-1 cells was performed as described (19). Mono-
clonal and polyclonal antibodies against the soluble granular proteins,
chromogranin B and secretogranin II (SgII), were as previously de-
scribed (19, 20). Anti-synaptophysin antibodies were obtained from
Roche Molecular Biochemicals.
Ca2 Imaging in Single Cells—Changes in [Ca2]i in single cells were
measured by the fura-2 method as described by Grynkiewicz et al. (21)
with minor modification (22). In brief, the culture medium was replaced
with balanced salt solution of the following composition: 150 mM NaCl,
5.0 mM KCl, 1.8 mM CaCl2, 1.2 mM MgCl2, 25 mM HEPES, and 10 mM
D-glucose, pH 7.4. Cells were loaded with fura-2 by incubation with 5 M
fura-2 acetoxymethylester (fura-2/AM) at room temperature (20–22 °C)
in balanced salt solution for 30 min, followed by a balanced salt solution
wash and a further 30-min incubation to allow de-esterification of the
loaded dye. Then the coverslips were mounted on a microscope (TMD-
300, Nikon, Tokyo, Japan) equipped with a xenon lamp and band pass
filters of 340- and 360-nm wavelength. Image data, recorded by a high
sensitivity silicon intensifier target camera (C-2741–08, Hamamatsu
Photonics, Hamamatsu, Japan) were regulated by a Ca2 analyzing
system (Furusawa Laboratory Appliances).
Confocal Ca2 Imaging—For recording subcellular Ca2 signals, the
cells were loaded with 5 M fluo-3/AM for 30–40 min at room temper-
ature. After a further 20–30 min for de-esterification of the acetoxy-
methyl ester, the coverslips were mounted on a microscope (E-600;
Nikon, Tokyo, Japan) equipped with a CSU-10 laser-scanning unit
(Yokogawa, Tokyo, Japan) and ICCD camera (C2400-87V; Hamamatsu
Photonics). Fluo-3 was excited with the 488-nm line of an argon ion
laser, and the emitted fluorescence was collected at wavelengths of
515 nm). A Nikon CFI Fluor 60 water immersion objective (1.0
numerical aperture) was used. In order to compensate for uneven dis-
tribution of the fluo-3, self ratios were calculated (Rs  F/F0), which
were subsequently converted into Ca2 concentration using the follow-
ing equation.
[Ca2]i Rs*Kd/Kd/[Ca2]rest)Rs (Eq. 1)
The Kd value of fluo-3 for PC12 cells was taken to be 707 nM, which was
determined by an in vivo calibration method (23).
Dopamine Release—The procedure for the measurement of released
dopamine was the same as that described by Koizumi et al. (22). The
FIG. 1. Western blotting analysis of
NCS-1. A, Western blotting analysis of
the PNS (40 mg of proteins) obtained from
brain, wild type PC12 cells (clone 251 and
N2), and PC12-N2 cells stably transfected
with the empty vector (E.V.) or cDNA cod-
ing for NCS-1 (#2) immunolabeled using
anti-NCS-1 antibody. B and C, Western
blotting analysis of sucrose gradient frac-
tions obtained as described under “Exper-
imental Procedures.” Aliquots containing
equivalent amounts of protein were col-
lected from each gradient and pelleted
with 80% acetone at 20 °C and analyzed
by immunoblotting using antibodies
against SgII, synaptophysin (Syn), or
NCS-1.
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amount of dopamine released to superfusate and that remaining in the
cells was determined by high performance liquid chromatography (HPLC)
coupled with an electrochemical detector (LC-4B; Bioanalytical Systems,
West Lafayette, IN). The percentage of release was calculated by dividing
supernatant values by the sum of supernatant and pellet values.
Assay of Phosphoinositides and Inositol 1,4,5-Trisphosphate
(Ins(1,4,5)P3)—Subconfluent cells were labeled with myo-[
3H]inositol (3
Ci/ml) for 48 h and were equilibrated for 15 min in the presence of 10
mM LiCl before challenge with UTP. Incubations were terminated by
the addition of an equal volume of 1 M trichloroacetic acid. The super-
natant was recovered and neutralized, and [3H]inositol phosphate
([3H]InsPx) accumulation was assessed as described previously (24).
Cell residues were extracted with acidified chloroform/methanol to re-
cover the total lipid fraction, and deacylation and separation of glycero-
phosphoinositol (phosphates) was performed (25). Experiments to
measure changes in Ins(1,4,5)P3 mass were performed as described
above except that cells were not prelabeled with myo-[3H]inositol, and
LiCl was omitted from the medium (26).
RESULTS
Subcellular Localization of Endogenous and Recombinant
NCS-1 in PC12 Cells—To determine the level of the expression
and subcellular distribution of NCS-1, wild type or NCS-1-
transfected PC12 cells were initially analyzed by immunoblot-
ting and subcellular fractionation. Using a specific antibody,
the levels of NCS-1 were analyzed in two different PC12 cell
clones (clones 251 and N2) and in a number of stable trans-
fected clones obtained from N2 cells (Fig. 1A). Whereas the
level of endogenous NCS-1 was similar in the wild type clones,
transfection with NCS-1 resulted in markedly enhanced levels
of expression in a number of selected clones. The clone selected
for further investigation (from here on referred to as NCS-1
cells) expressed 	6 times more NCS-1 than the wild type N2
cells.
FIG. 2. Immunocytochemical analy-
sis of NCS-1. A–B
, double immunofluo-
rescence micrographs showing the distri-
bution of NCS-1 in NCS-1 cells. After
fixation, cells were double immuno-
stained with anti-NCS-1 antibody (A and
B) together with either anti-synaptophy-
sin (A) or anti-chromogranin B (B) anti-
bodies. A
 and B
, superimposed images.
Note a partial colocalization of NCS-1
with synaptophysin (A
; yellow staining).
Bar, 10 m. C and D show the subcellular
localization of NCS-1. Ultrathin frozen
sections of NCS-1 cells were immunola-
beled with the anti-NCS-1 antibody fol-
lowed by anti-rabbit IgG conjugated to
5-nm (C) or 10-nm (D) gold particles. The
arrows indicate the presence of NCS-1 in
small vesicle tubular structures (C and D)
and the plasma membrane (D). Bars, 100
nm.
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FIG. 3. Concentration dependence of Ca2 responses to UTP in NCS-1 cells compared with control cells. A, a and b, typical Ca2
responses to UTP in the presence and absence of Ca2o, respectively. Upper and lower traces show Ca
2 responses in control and NCS-1 cells,
respectively. The traces represent averaged responses from 32–56 cells. Cells were stimulated with various concentrations of UTP (0.1–300 M) for
20 s separated by 5 min in the presence (a) and absence (b) of Ca2o. b, Ca
2 (1.8 mM) was readmitted to the medium for 2 min between UTP
stimulation to allow the stores to refill. A (c) shows the UTP-evoked elevation in [Ca2]i in another NCS-1-expressing clonal cell, clone 3 (with
NCS-1 levels greater than control but less than that of NCS-1 cells). The upper Western blotting panel shows the level of NCS-1 in each clone.
Typical traces of the UTP (100 M)-evoked rises in [Ca2]i are shown just below the corresponding blot. The responses are summarized in the
bottom column, which was normalized to the response of control cells. B (a) shows concentration-response curves for UTP-, bradykinin-, and high
K-evoked elevation of [Ca2]i in control and NCS-1 cells. Similar to UTP, bradykinin (1–100 nM) was added to the cells for 20 s every 5 min. Ca
2
responses in control (open circles) and NCS-1 cells (closed circles) were plotted against the agonist concentration. The closed square shows high
K-evoked [Ca2]i elevation in clone 3 cells. B (b) shows concentration-response curves for UTP- and bradykinin-evoked elevations of [Ca
2]i in the
clones in the absence of Ca2o. The data are mean  S.E. of 58–112 cells. Curves were fitted using a Hill equation. C, a and d illustrate typical
traces of Ca2 release evoked by cyclopiazonic acid (horizontal open bars) and Ca2 entry evoked by the readdition of Ca2o in control (a) and NCS-1
cells (d). Cells were stimulated with cyclopiazonic acid (30 M) for 4 min in the absence of Ca2o and washed by Ca
2-free medium for another 1
min, and then Ca2o was readded. The traces represent averaged responses from 47 (a) and 51 (d) cells. C, b and e indicate typical traces of Ca
2
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Data from subcellular fractionation indicated a broad distri-
bution of NCS-1 in transfected cells. As reported (5), a certain
portion of NCS-1 was soluble in the cytosol. To study the
distribution of the portion of protein associated with cellular
organelles, the PNS were subjected to high speed centrifuga-
tion, and the pellets were resuspended in homogenization
buffer. These were then analyzed by subcellular fractionation
using two-step gradients. Analysis of the fractions obtained
from the first (velocity) gradients, which separates organelles
according to their size, revealed a broad distribution of NCS-1.
In these velocity gradients, two peaks of NCS-1 were observed:
one in the lighter fractions and the second in fractions 7–9 (Fig.
1B). This distribution is similar to that of synaptophysin, a
protein present in the membrane of vesicles highly related to
synaptic vesicles (referred to as synaptic-like microvesicles)
(27) and known to recycle through the early endosomal com-
partment in PC12 cells (28, 29). A well known marker of the
secretory granules, SgII (30), peaked in fractions 4–8, where
some synaptophysin and NCS-1 were also present. In order to
further analyze whether a portion of NCS-1 could be present in
the membranes of secretory granules, aliquots of fractions 4–8
were collected and loaded on the equilibrium gradients in order
to achieve separation of organelles according to their density.
Western blotting analysis of the fractions from these gradients
revealed the presence of NCS-1 mainly in the earlier fractions.
This distribution was again very similar to that of synaptophy-
sin. There was no colocalization of NCS-1 with the marker for
secretory granules, SgII, which was in the denser fractions.
The cellular localization of NCS-1 in stably transfected PC12
cells was also studied by immunofluorescence and immunocy-
tochemistry. As shown in Fig. 2, A and B, when NCS-1 cells
were labeled with NCS-1 antibodies, intense immunofluores-
cence was seen in a large number of cells (about 60%). The
immunostaining for NCS-1 was partially diffuse in the positive
cells in agreement with its partial distribution in the cytosol
(Fig. 2, A and B) (5). The anti-NCS-1 antibody also gave a
punctate staining and showed partial colocalization with the
immunostaining pattern of synaptophysin (see Fig. 2, A–A
). In
contrast, very little colocalization was observed with the im-
munofluorescent pattern of chromogranin B, a well known
marker for the secretory granules of PC12 cells (Fig. 2, B–B
).
In addition, NCS-1 immunostaining was observed at the pe-
riphery of the positive cells, raising the possibility that a cer-
tain amount of the protein could be bound to the plasma mem-
brane. To confirm this possibility, ultrathin frozen sections
prepared from NCS-1 cells were immunolabeled with anti-
NCS-1 antibodies and secondarily labeled with anti-rabbit IgG
conjugated to 5-nm gold particles. As shown in Fig. 2, C and D,
this revealed intracellular NCS-1 immunoreactivity, with gold
particles distributed both in the cytoplasm and on small clear
vesicles and tubules. In line with the immunofluorescence data,
some gold particles were also found to decorate the plasma
membrane, thus confirming the presence of NCS-1 at the cell
surface in NCS-1 cells.
Enhancement by NCS-1 of Ca2 Responses to UTP or Brady-
kinin—Stimulation of PC12 cells with the P2Y2-selective ago-
nist UTP results in the activation of phospholipase C (PLC) and
the subsequent generation of Ins(1,4,5)P3. Indeed, U73122 (10
M), an inhibitor of PLC, substantially decreased the UTP-
evoked elevation in intracellular Ca2 concentration ([Ca2]i)
in the cells. In the presence of U73122, the UTP-evoked [Ca2]i
was decreased by 93.3  0.5% (n  53 cells from two independ-
ent experiments). In PC12 cells, the normal consequence of
UTP stimulation is the rapid release of Ca2 from intracellular
Ins(1,4,5)P3-sensitive stores, followed by a more sustained
Ca2 entry across plasma membrane in response to store de-
pletion (capacitative Ca2 entry (CCE)) (31). In the current
study, a brief UTP stimulation caused a transient pattern of
[Ca2]i elevation consistent with Ca
2 mobilization and CCE in
bothvector-transfectedcontrolandNCS-1cellsinaconcentration-
dependent manner (Fig. 3A). However, UTP was significantly
more potent in NCS-1 cells than in control cells (EC50  19 and
81 M, respectively). Furthermore, the maximal [Ca2]i re-
sponses evoked by 300 M UTP were significantly greater in
NCS-1 cells than control cells (363  52 nM versus 269  31 nM,
p  0.05). The enhancement of Ca2 responses was not a clonal
artifact, because in another NCS-1-expressing clonal cell line
(clone 3) whose NCS-1 levels are greater than control but less
than that of NCS-1 cells, UTP was more potent than in control
cells (Fig. 3A, c). Bradykinin also elevates [Ca2]i in PC12 cells
via the PLC-coupled bradykinin B2 receptor (32). Similar to the
UTP-mediated responses, bradykinin elevated [Ca2]i in
NCS-1 cells more potently than in control cells (EC50 values;
6.0 and 8.5 nM, respectively), and the maximal response was
again enhanced (315  34 nM versus 232  21 nM, p  0.05; 100
nM bradykinin) (Fig. 3B). This enhancement by NCS-1 of both
UTP- and bradykinin-evoked Ca2 signaling in NCS-1 cells
was also apparent in the absence of extracellular Ca2 (Ca2o)
(Fig. 3, A (b) and B (b)), indicating that the Ca2 release process
had itself been potentiated. U73122 (10 M) also inhibited the
Ca2 responses to UTP in NCS-1 cells ([Ca2]i elevation was
5.3  0.62% of that with UTP alone; n  52 cells from two
independent experiments). In contrast to these differences in
UTP- and bradykinin-evoked responses between NCS-1 cells
and control cells, the elevations in [Ca2]i evoked by depolar-
ization with high K (25–100 mM) were almost identical in
control and NCS-1 cells (Fig. 3B, a).
To ascertain whether the CCE process per se was affected by
NCS-1, we determined CCE directly in control and NCS-1 cells.
CCE was activated by inhibiting the Ca2-ATPase of the en-
doplasmic reticulum using cyclopiazonic acid (30 M). The ele-
vations of [Ca2]i induced by cyclopiazonic acid were not dif-
ferent in control and NCS-1 cells (Fig. 3C, a and d; 117.2 
16.5% of control, p  0.05, n  32 cells), indicating that CCE
per se was unaffected by overexpression of NCS-1. We next
monitored Ca2 release and CCE separately to investigate the
relationship between UTP-evoked Ca2 release and Ca2 en-
try. In the absence of Ca2o, UTP produced concentration-de-
pendent elevations of [Ca2]i in both control and NCS-1 cells
(Fig. 3C, b and e). After the removal of UTP, readdition of Ca2o
produced a sustained rise in [Ca2]i, which slowly returned to
basal levels after 	10 min. This rise was a consequence of CCE
and was dependent upon the initial UTP concentration (Fig.
3C, b, c, e, and f). In other words, the extent of CCE is related
to the extent of the UTP-mediated store depletion.
In addition to Ins(1,4,5)P3 receptors, PC12 cells express func-
tional type 2 ryanodine receptors on intracellular Ca2 stores
(33, 34). Activation of these Ca2 release channels with 40 mM
caffeine caused a rapid transient elevation in [Ca2]i of similar
magnitude in control and NCS-1 cells (85.7  19.2% of control,
release evoked by various concentrations of UTP (10–1000 M, shown on the left side of each trace) in the absence of Ca2o and Ca
2 entry evoked
by readdition of Ca2o in control (b) and NCS-1 cells (e). The traces represent averaged responses from 28–54 cells. Cells were stimulated with UTP
for 2 min (horizontal closed bars) and washed by UTP-free/Ca2-free medium for another 1 min, and then Ca2 (1.8 mM) was readded. Ca2
responses in C (b) and C (e) are summarized in C (c) and C (f), respectively. The maximal Ca2 release (open circles) and Ca2 entry (closed circles)
were plotted against the UTP concentration. The amplitude of initial Ca2 release correlates to that of the subsequent Ca2 entry in both clones.
Curves were fitted using a Hill equation.
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FIG. 4. Characterization of elementary Ca2 events in PC12 cells. A, a phase-contrast image of NCS-1 cells. Each trace in B shows the time
course of spontaneous and UTP (0.3 M)-evoked changes in [Ca2]i at sites a–c in A. Characteristic features of these elementary Ca
2 release
signals are summarized in C and D. In C, bars and circles indicate the fraction of cells that showed elementary Ca2 release signals and the number
of initiation sites for the elementary events (per cell) in the absence (UTP) or presence of UTP (UTP), respectively. In D, bars and circles show
event amplitude and frequency of spontaneous or the UTP (0.3 M)-evoked Ca2 release events, respectively. The data are mean  S.E. of 58–79
cells. Statistical analysis was performed by paired Student’s t test. E (a) illustrates pseudocolor images of an elementary Ca2 release event
(arrowhead) evoked by 0.1 M UTP in an NCS-1 cell. A higher UTP concentration (3 M) applied subsequently resulted in a global Ca2 response
(E (b)). The time course of the UTP-evoked rise in [Ca2]i at the site indicated by the arrowhead in E is plotted in F.
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n  23 cells from two independent experiments). Since we have
reported that luminal [Ca2] affects the activity of both
Ins(1,4,5)P3 receptors and ryanodine receptors in PC12 cells
(35, 36), the Ca2 contents of the intracellular stores in control
and NCS-1 cells were compared. In the absence of Ca2o, iono-
mycin (5 M) releases almost all Ca2 from the intracellular
FIG. 5. Enhancement of UTP-
evoked secretion by NCS-1. The HPLC
assays of the UTP- and high K-evoked
release of dopamine in the control, NCS-1,
and clone 3 cells are shown. These are
results from a typical experiment, with
each data point being the mean  S.E. of
triplicate measurements. Open circles,
filled circles, and filled squares show the
responses in control cells, NCS-1 cells,
and clone 3 cells, respectively. Open and
closed triangles show the UTP (100 M)-
evoked dopamine release in the absence
of Ca2o in control and NCS-1 cells, re-
spectively. Three such experiments were
performed and similar results were ob-
tained. The release of dopamine is shown
as a percentage of the total cellular con-
tent. Statistical analysis was performed
by paired Student’s t test.
FIG. 6. Comparison of the intracellu-
lar phosphoinositides levels in both
clones. A, a–d show intracellular concen-
trations of [3H]PtdIns, [3H]PtdIns(4)P,
[3H]PtdIns(4,5)P2, and [
3H]InsPx in the ab-
sence (Basal) and presence of 300 M UTP
(UTP) in both clones. Open and closed
columns show the amount of these phos-
pholipids in vector control and NCS-1 cells,
respectively. Cells were labeled with [3H]
inositol for 48 h and then stimulated with
UTP for 60 s as described under “Experi-
mental Procedures.” Values shown are
dpm/mg of protein. All data are presented
as mean  S.E. of seven experiments per-
formed on three different days. Statistical
significance is indicated as p  0.05 (),
p  0.01 (), and p  0.001 () for
basal NCS-1 cells versus vector control val-
ues and as p  0.001 (***) for basal versus
UTP stimulated values. B, time courses of
UTP-evoked Ins(1,4,5)P3 generation in
control (open circles) and NCS-1 cells
(closed squares). Ins(1,4,5)P3 levels were
determined by radioreceptor assay and ex-
pressed as percentage of basal levels which
were 20.1  3.6 and 24.1  2.9 pmol/mg of
protein for vector controls and NCS-1 cells,
respectively. All data are mean  S.E. of
four independent experiments, each per-
formed in duplicate. Statistical significance
is shown as p  0.05 (*) and p  0.01 (**)
for NCS-1 cells compared with vector con-
trol (Student’s t test).
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stores of PC12 cells (37). In NCS-1 cells, ionomycin-mediated
elevations in [Ca2]i were similar to those in control cells
(96.1  6.3% of control, n  32 cells from two independent
experiments), indicating similar luminal Ca2 contents in the
two cell lines.
Elementary Ca2 Release Events in NCS-1 Cells—Elemen-
tary Ca2 release signals, such as puffs and sparks, are the
building blocks for global Ca2 signals (38, 39). Such elemen-
tary events have been observed in a wide variety of cell types
including PC12 cells (35). Thus, using confocal microscopy, we
investigated whether overexpression of NCS-1 affects elemen-
tary Ca2 release events. Elementary Ca2 signals were ob-
served spontaneously (Fig. 4B, left traces), and these were
facilitated upon stimulation with UTP concentrations (0.1 or
0.3 M) that were subthreshold for global Ca2 signaling. These
elementary Ca2 events were observed even in the absence of
Ca2o, suggesting that they were mainly due to Ca
2 release
from Ca2 stores. Low concentration (0.3 M) of UTP increased
both the number of responding cells and the number of active
elementary Ca2 release sites (Fig. 4C), and enhanced the
event amplitude and frequency (Fig. 4D). When NCS-1 cells
were stimulated with higher (e.g. 3 M) concentrations of UTP,
these elementary events were followed by global Ca2 signals
(Fig. 4, E and F). In control cells, spontaneous elementary Ca2
events also occurred, but there were no significant differences
with NCS-1 cells in either the proportion of cells in which
events were observed or the event amplitude. However, in
control cells, 0.3 M UTP activated fewer additional elementary
Ca2 release sites in fewer cells. Furthermore, the frequency of
UTP-stimulated elementary events was lower than that seen in
NCS-1 cells. These data demonstrate that overexpression of
NCS-1 enhanced elementary Ca2 release events mediated by
PLC-linked GPCRs, and as a consequence the NCS-1-express-
ing cells displayed global Ca2 signals at low levels of
stimulation.
NCS-1 Enhances Secretion Evoked by UTP but Not by High
K—UTP evokes the release of dopamine from PC12 cells (31),
and the effects of NCS-1 overexpression on UTP-evoked secre-
tory responses were therefore investigated. The UTP-evoked
release of dopamine into the superfusate was determined by
HPLC. UTP caused the release of dopamine in a concentration-
dependent manner in control and NCS-1 cells. At each UTP
concentration, there was a significantly greater release of do-
pamine in NCS-1 cells compared with control cells (Fig. 5). We
also examined the UTP-evoked release of dopamine in clone 3
cells (see Fig. 3A, c). The dopamine release by clone 3 cells was
greater than control but less than that of NCS-1 cells. This
UTP-evoked release of dopamine was dependent on Ca2o in all
cell lines (Fig. 5, triangles). There was no significant difference
in spontaneous or high K (25–100 mM)-evoked dopamine re-
lease between control, NCS-1 and clone 3 cells. In addition, no
significant difference was observed in total cellular dopamine
content between the clones (control, 287.8  22.6 (n  9);
NCS-1 cell, 291.6  30.7 (n  9) ng/dish; p  0.05).
Enhancement of Phosphoinositide Signaling by NCS-1—Fi-
nally, the levels of various phosphoinositides in both clones
were investigated (Fig. 6). Under basal conditions, there was no
significant difference in [3H]PtdIns levels between the two
clones (Fig. 6A, a). In control cells, [3H]phosphatidylinositol
4-phosphate (PtdIns(4)P) and [3H]PtdIns(4,5)P2 represented
1.0 and 2.2% of the total phosphoinositide pool, respectively. In
NCS-1 cells, the levels of both PtdIns(4)P and PtdIns(4,5)P2
were significantly increased to 2.2 and 3.7% of the total phos-
phoinositide pool, respectively (Fig. 6A, a–c). Stimulation of
both clones with UTP (300 M) resulted in accumulation of
[3H]InsPx against a Li
 block of inositol monophosphatase (Fig.
6A, d). The response to UTP was significantly enhanced in
NCS-1 cells such that accumulation was greater (198% over
basal at 20 min compared with 83% in vector controls) (Fig. 6A,
d). UTP caused an increase in Ins(1,4,5)P3 mass in control cells
(Fig. 6B). There was a marked potentiation in the magnitude
(228% over basal level at 20 s compared with 146% in vector
controls) and the duration of the Ins(1,4,5)P3 response to UTP
in NCS-1 cells (Fig. 6B).
DISCUSSION
Subcellular Localization of NCS-1 and Implications for Its
Functional Role—NCS-1 showed a broad subcellular localiza-
tion in PC12 cells, being partially distributed in the cytoplasm
and associated with vesicles and tubular-like structures. The
morphological and biochemical results suggest that some
NCS-1 may be associated with the membrane of the synaptic-
like microvesicles. In contrast to previous observations (5), our
results demonstrate that NCS-1 is mainly not associated with
the membranes of secretory granules. Interestingly, NCS-1 is
also associated with the plasma membrane. This localization
may be consistent with the possible role of NCS-1 in the mod-
ulation of the function of plasma membrane channels and
receptors (40), especially of voltage-gated Ca2 channels (7–9).
On the other hand, NCS-1 at the plasma membrane and on
vesicle membranes may play an important role in the metabo-
lism of phosphoinositides. This phospholipid family is involved
in both signal transduction and also in vesicle formation from
the plasma membrane, trans-Golgi network and endosomes
(41). In yeast, the homologue of NCS-1 has been demonstrated
to exist in a complex with and to activate the yeast PtdIns4K,
phosphatidylinositol 4-OH kinase (1), and very recent data
have shown a direct interaction of NCS-1 with PtdIns4K in
eukaryotic cells as well (42). The membranous distribution of
NCS-1 in the present study raises the possibility that NCS-1
may contribute to the activation and recruitment of PtdIns4K
to the plasma membrane (or other organelles), allowing an
increase of PtdIns metabolism and synthesis of the signaling
molecule Ins(1,4,5)P3, which therefore would affect subsequent
FIG. 7. Diagram illustrating a working model for the regula-
tion of Ca2 signals and secretion by NCS-1 in PC12 cells. See
“Discussion” for details.
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intracellular responses such as Ca2 signaling and exocytosis
(see Fig. 7).
Overexpression of NCS-1 Enhances Elementary and Global
Ca2 Signaling and Secretory Responses—PC12 cells express
both voltage- (43) and ligand-gated channels (44) through
which Ca2 entry is able to evoke exocytosis. Of particular
relevance to the current study, PC12 cells express P2X2 non-
selective cation channels (45). Although ATP effectively acti-
vates this receptor, UTP evokes little (0–6% of the maximal
ATP response) (46) or no (45) current through this channel.
UTP-mediated [Ca2]i responses in these cells can therefore be
considered to be mediated via activation of PLC-coupled, P2Y2
receptors. Despite the ability of UTP to elevate [Ca2]i in the
absence of Ca2o, the effects of UTP on exocytosis were totally
dependent upon Ca2o. We demonstrated that the entry of
Ca2 across the plasma membrane is a consequence of CCE
and that its magnitude is dependent upon the amplitude of the
UTP-evoked elevation of [Ca2]i (as an index of the extent of
store depletion). Thus, CCE, in response to the depletion of
intracellular Ca2 stores, links the activation of PLC-coupled
P2Y2 receptors to exocytotic events in PC12 cells. The findings
that bradykinin-evoked release of [3H]noradrenaline from
PC12 cells was largely inhibited either by the removal of Ca2o
or by the addition of SK&F96365, an inhibitor of CCE (47) and
that caffeine-mediated release of Ca2 from intracellular stores
via ryanodine receptors triggers secretion from PC12 cells in a
manner dependent upon Ca2o (34, 48) further support the role
of CCE in exocytosis.
NCS-1 did not influence depolarization (high K)-evoked
exocytosis, supporting a previous observation that Ca2 sensi-
tivity of the exocytotic process is not affected by NCS-1 over-
expression (5). In addition, the effect of NCS-1 on voltage-gated
Ca2 channels in PC12 cells appears to be negligible. The
ability of NCS-1 to enhance exocytosis in PC12 cells therefore
implies that this protein enhances CCE. However, CCE result-
ing from store depletion by inhibition of the endoplasmic retic-
ulum Ca2-ATPase with cyclopiazonic acid was unaffected.
Furthermore, there was no difference in stored Ca2 contents
or in responses to caffeine between the clones (see “Results”).
These data demonstrate that the CCE mechanism per se was
not potentiated by NCS-1 overexpression and indicate that
NCS-1 exerts its effects on secretion through enhanced GPCR-
mediated Ca2 release from intracellular stores. Our data are
fully in accord with this hypothesis and demonstrate that over-
expression of NCS-1 enhances elementary and global Ca2
signaling in response to GPCR activation. Although the ampli-
tudes of the initial, transient agonist-mediated global Ca2
signaling events were in excess of the more sustained elevation
due to CCE, the former were unable to evoke exocytosis. This is
in agreement with previous studies demonstrating that CCE in
response to depletion of either Ins(1,4,5)P3- or ryanodine-sen-
sitive stores triggers exocytosis more efficiently than the Ca2
release process (31, 34, 48, 49). The reason for this is unclear.
The exocytotic Ca2 sensors appear to possess a low affinity for
Ca2, requiring 10–100 M for activation (50, 51). Although
global measurements following depolarization reveal [Ca2]i
on the order of 1 M in many cell types, it is believed that much
higher local [Ca2]i is achieved in subplasmalemmal microdo-
mains due to the spatial packing of voltage-gated Ca2 chan-
nels (52, 53). It is likely, therefore, that the spatial arrange-
ment of Ca2 channels (e.g. CCE channels and Ins(1,4,5)P3
receptors) and the exocytotic machinery dictate whether Ca2
fluxes are able to regulate vesicular release.
Overexpression of NCS-1 also enhanced the elementary
Ca2 release events. Such elementary Ca2 signals were brief
(lifetime 	1 s) [Ca2]i increases with a spatial spread of 	3–6
m. In control cells, the amplitudes of the elementary events
typically ranged from 80 to 100 nM, and the frequency was
generally less than 0.1 Hz (0.06–0.1 Hz). All of these charac-
teristic features are well in accord with elementary Ca2
events previously described in nerve growth factor-differenti-
ated PC12 cells (35). Without stimulation (UTP), there was
little difference in the characteristics of elementary Ca2 re-
lease events between control and NCS-1 cells. However, upon
stimulation with UTP, the number of cells showing elementary
Ca2 signals increased, as did the number of active elementary
Ca2 release sites within individual cells. In addition, the
frequency of the events was dramatically enhanced. Global
Ca2 signals arise via the coordinated recruitment of elemen-
tary Ca2 release sites (35, 39, 54). The potentiation of elemen-
tary Ca2 signaling in NCS-1 cells therefore underlies their
propensity to show global Ca2 signals with low UTP
concentrations.
Overexpression of NCS-1 Increases the Level of Polyphospho-
inositides and Facilitates Agonist-mediated Ins(1,4,5)P3 Pro-
duction—Varieties of mechanisms have been proposed to ac-
count for the role of NCS-1 in synaptic enhancement and in
exocytosis. Probable explanations for the NCS-1-evoked en-
hancement may be due to modulation of ion channels such as
voltage-gated Ca2 channels (7–9) and A-type K channels
(10). Recently, NCS-1 has been identified as an upstream acti-
vator of a specific isoform of PtdIns4K, phosphatidylinositol
4-OH kinase, in yeast (1). Here we demonstrated that in PC12
cells vertebrate NCS-1 significantly increased the levels of both
PtdIns(4)P and PtdIns(4,5)P2 without affecting those of PtdIns
and facilitated Ins(1,4,5)P3 production in response to UTP, an
agonist to PLC-linked GPCRs. We therefore propose the fol-
lowing model for mechanisms that may underlie the enhance-
ment by NCS-1 of exocytosis (see Fig. 7). First, NCS-1 binds to
PtdIns4K located on the plasma membrane (or synaptic vesi-
cles) and up-regulates its activity. This is followed by an in-
crease in the local production of PtdIns(4)P and PtdIns(4,5)P2,
which serves as substrate for PLC, resulting in an increase in
the production of Ins(1,4,5)P3 and diacylglycerol in response to
UTP (or bradykinin). This local increase in Ins(1,4,5)P3 evokes
elementary and global Ca2 responses including both Ca2
release via the Ins(1,4,5)P3 receptor and CCE, leading to an
enhancement of the secretory response. The dynamics of the
interaction between PtdIns4K and NCS-1 remain to be inves-
tigated in detail. The fact that the interaction and activation of
phosphatidylinositol 4-OH kinase/PtdIns4K is dependent on
the myristoylation of NCS-1 suggests that the interaction
should occur in a membranous environment. NCS-1, which is
also present on the synaptic vesicle fraction, could translocate
to the plasma membrane upon stimulation and thereby either
recruit PtdIns4K to the plasmamembrane or activate preexist-
ing PtdIns4K (55). The stable PC12 cells now allow us to
address these issues.
In summary, we have for the first time demonstrated a role
of mammalian NCS-1, as an important member of this family
of EF-hand of Ca2-binding proteins, in phosphoinositide turn-
over, Ca2 signaling, and exocytosis. We have presented evi-
dence that NCS-1 enhances exocytosis by increasing Ca2 sig-
naling, which involves enhanced generation of Ins(1,4,5)P3.
This is a novel regulatory mechanism of exocytosis that might
involve the activation of PtdInd4K. The revealed regulatory
mechanisms would provide the basis to study their importance
in other neurosecretory cells such as chromaffin cells or
neurons.
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